Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
6 "Dae Kyung Sohn"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer
Ji Eun Oh, Min Ju Kim, Joohyung Lee, Bo Yun Hur, Bun Kim, Dae Yong Kim, Ji Yeon Baek, Hee Jin Chang, Sung Chan Park, Jae Hwan Oh, Sun Ah Cho, Dae Kyung Sohn
Cancer Res Treat. 2020;52(1):51-59.   Published online May 7, 2019
DOI: https://doi.org/10.4143/crt.2019.050
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Mutation of the Kirsten Ras (KRAS) oncogene is present in 30%-40% of colorectal cancers and has prognostic significance in rectal cancer. In this study, we examined the ability of radiomics features extracted from T2-weighted magnetic resonance (MR) images to differentiate between tumors with mutant KRAS and wild-type KRAS.
Materials and Methods
Sixty patients with primary rectal cancer (25 with mutant KRAS, 35 with wild-type KRAS) were retrospectively enrolled. Texture analysis was performed in all regions of interest on MR images, which were manually segmented by two independent radiologists. We identified potentially useful imaging features using the two-tailed t test and used them to build a discriminant model with a decision tree to estimate whether KRAS mutation had occurred.
Results
Three radiomic features were significantly associated with KRASmutational status (p < 0.05). The mean (and standard deviation) skewness with gradient filter value was significantly higher in the mutant KRAS group than in the wild-type group (2.04±0.94 vs. 1.59±0.69). Higher standard deviations for medium texture (SSF3 and SSF4) were able to differentiate mutant KRAS (139.81±44.19 and 267.12±89.75, respectively) and wild-type KRAS (114.55±29.30 and 224.78±62.20). The final decision tree comprised three decision nodes and four terminal nodes, two of which designated KRAS mutation. The sensitivity, specificity, and accuracy of the decision tree was 84%, 80%, and 81.7%, respectively.
Conclusion
Using MR-based texture analysis, we identified three imaging features that could differentiate mutant from wild-type KRAS. T2-weighted images could be used to predict KRAS mutation status preoperatively in patients with rectal cancer.

Citations

Citations to this article as recorded by  
  • A multicenter study: predicting KRAS mutation and prognosis in colorectal cancer through a CT-based radiomics nomogram
    Manman Li, Yiwen Yuan, Hui Zhou, Feng Feng, Guodong Xu
    Abdominal Radiology.2024; 49(6): 1816.     CrossRef
  • SG-Transunet: A segmentation-guided Transformer U-Net model for KRAS gene mutation status identification in colorectal cancer
    Yulan Ma, Yuzhu Guo, Weigang Cui, Jingyu Liu, Yang Li, Yingsen Wang, Yan Qiang
    Computers in Biology and Medicine.2024; 173: 108293.     CrossRef
  • CHNet: A multi-task global–local Collaborative Hybrid Network for KRAS mutation status prediction in colorectal cancer
    Meiling Cai, Lin Zhao, Yan Qiang, Long Wang, Juanjuan Zhao
    Artificial Intelligence in Medicine.2024; 155: 102931.     CrossRef
  • Assessment of prognostic indicators and KRAS mutations in rectal cancer using a fractional-order calculus MR diffusion model: whole tumor histogram analysis
    Mi Zhou, Hongyun Huang, Deying Bao, Meining Chen, Fulin Lu
    Abdominal Radiology.2024;[Epub]     CrossRef
  • The Role of Predictive and Prognostic MRI-Based Biomarkers in the Era of Total Neoadjuvant Treatment in Rectal Cancer
    Sebastian Curcean, Andra Curcean, Daniela Martin, Zsolt Fekete, Alexandru Irimie, Alina-Simona Muntean, Cosmin Caraiani
    Cancers.2024; 16(17): 3111.     CrossRef
  • A segmentation-based sequence residual attention model for KRAS gene mutation status prediction in colorectal cancer
    Lin Zhao, Kai Song, Yulan Ma, Meiling Cai, Yan Qiang, Jingyu Sun, Juanjuan Zhao
    Applied Intelligence.2023; 53(9): 10232.     CrossRef
  • Rectal MRI Interpretation After Neoadjuvant Therapy
    Natally Horvat, Maria El Homsi, Joao Miranda, Yousef Mazaheri, Marc J. Gollub, Viktoriya Paroder
    Journal of Magnetic Resonance Imaging.2023; 57(2): 353.     CrossRef
  • Association between Dynamic Contrast-Enhanced MRI Parameters and Prognostic Factors in Patients with Primary Rectal Cancer
    Hye Ri Kim, Seung Ho Kim, Kyung Han Nam
    Current Oncology.2023; 30(2): 2543.     CrossRef
  • Virtual biopsy in abdominal pathology: where do we stand?
    Arianna Defeudis, Jovana Panic, Giulia Nicoletti, Simone Mazzetti, Valentina Giannini, Daniele Regge
    BJR|Open.2023;[Epub]     CrossRef
  • Repeatability of radiomics studies in colorectal cancer: a systematic review
    Ying Liu, Xiaoqin Wei, Xu Feng, Yan Liu, Guiling Feng, Yong Du
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • The Role of Radiomics in Rectal Cancer
    Joao Miranda, Natally Horvat, Jose A. B. Araujo-Filho, Kamila S. Albuquerque, Charlotte Charbel, Bruno M. C. Trindade, Daniel L. Cardoso, Lucas de Padua Gomes de Farias, Jayasree Chakraborty, Cesar Higa Nomura
    Journal of Gastrointestinal Cancer.2023; 54(4): 1158.     CrossRef
  • Radiomics and Radiogenomics in Pelvic Oncology: Current Applications and Future Directions
    Niall J. O’Sullivan, Michael E. Kelly
    Current Oncology.2023; 30(5): 4936.     CrossRef
  • Construction of prediction model for KRAS mutation status of colorectal cancer based on CT radiomics
    Yuntai Cao, Jing Zhang, Lele Huang, Zhiyong Zhao, Guojin Zhang, Jialiang Ren, Hailong Li, Hongqian Zhang, Bin Guo, Zhan Wang, Yue Xing, Junlin Zhou
    Japanese Journal of Radiology.2023; 41(11): 1236.     CrossRef
  • Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review
    Giuseppe Di Costanzo, Raffaele Ascione, Andrea Ponsiglione, Anna Giacoma Tucci, Serena Dell’Aversana, Francesca Iasiello, Enrico Cavaglià
    Exploration of Targeted Anti-tumor Therapy.2023; : 406.     CrossRef
  • Investigating the Feasibility of Predicting KRAS Status, Tumor Staging, and Extramural Venous Invasion in Colorectal Cancer Using Inter-Platform Magnetic Resonance Imaging Radiomic Features
    Mohammed S. Alshuhri, Abdulaziz Alduhyyim, Haitham Al-Mubarak, Ahmad A. Alhulail, Othman I. Alomair, Yahia Madkhali, Rakan A. Alghuraybi, Abdullah M. Alotaibi, Abdullalh G. M. Alqahtani
    Diagnostics.2023; 13(23): 3541.     CrossRef
  • Radiogenomics: Contemporary Applications in the Management of Rectal Cancer
    Niall J. O’Sullivan, Hugo C. Temperley, Michelle T. Horan, Alison Corr, Brian J. Mehigan, John O. Larkin, Paul H. McCormick, Dara O. Kavanagh, James F. M. Meaney, Michael E. Kelly
    Cancers.2023; 15(24): 5816.     CrossRef
  • KRAS status predicted by pretreatment MRI radiomics was associated with lung metastasis in locally advanced rectal cancer patients
    Yirong Xiang, Shuai Li, Maxiaowei Song, Hongzhi Wang, Ke Hu, Fengwei Wang, Zhi Wang, Zhiyong Niu, Jin Liu, Yong Cai, Yongheng Li, Xianggao Zhu, Jianhao Geng, Yangzi Zhang, Huajing Teng, Weihu Wang
    BMC Medical Imaging.2023;[Epub]     CrossRef
  • Segmentation-based multi-scale attention model for KRAS mutation prediction in rectal cancer
    Kai Song, Zijuan Zhao, Jiawen Wang, Yan Qiang, Juanjuan Zhao, Muhammad Bilal Zia
    International Journal of Machine Learning and Cybernetics.2022; 13(5): 1283.     CrossRef
  • A multitask dual‐stream attention network for the identification of KRAS mutation in colorectal cancer
    Kai Song, Zijuan Zhao, Yulan Ma, JiaWen Wang, Wei Wu, Yan Qiang, Juanjuan Zhao, Suman Chaudhary
    Medical Physics.2022; 49(1): 254.     CrossRef
  • Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data
    Emilia Sardo, Stefania Napolitano, Carminia Maria Della Corte, Davide Ciardiello, Antonio Raucci, Gianluca Arrichiello, Teresa Troiani, Fortunato Ciardiello, Erika Martinelli, Giulia Martini
    Journal of Personalized Medicine.2022; 12(2): 128.     CrossRef
  • The application of radiomics in predicting gene mutations in cancer
    Yana Qi, Tingting Zhao, Mingyong Han
    European Radiology.2022; 32(6): 4014.     CrossRef
  • The prognostic effect of PNN in digestive tract cancers and its correlation with the tumor immune landscape in colon adenocarcinoma
    Hui Zhang, Ming Jin, Meng Ye, Yanping Bei, Shaohui Yang, Kaitai Liu
    Journal of Clinical Laboratory Analysis.2022;[Epub]     CrossRef
  • 18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
    Giulia Capelli, Cristina Campi, Quoc Riccardo Bao, Francesco Morra, Carmelo Lacognata, Pietro Zucchetta, Diego Cecchin, Salvatore Pucciarelli, Gaya Spolverato, Filippo Crimì
    Nuclear Medicine Communications.2022; 43(7): 815.     CrossRef
  • Radiomics model based on multi-sequence MR images for predicting preoperative immunoscore in rectal cancer
    Kaiming Xue, Lin Liu, Yunxia Liu, Yan Guo, Yuhang Zhu, Mengchao Zhang
    La radiologia medica.2022; 127(7): 702.     CrossRef
  • Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells
    Sukanya Unson, Tung-Cheng Chang, Yung-Ning Yang, Shwu-Huey Wang, Chi-Hung Huang, Dana R. Crawford, Haw-Ming Huang, Zi-Lin Li, Hung-Yun Lin, Jacqueline Whang-Peng, Kuan Wang, Paul J. Davis, Wen-Shan Li
    Marine Drugs.2022; 20(8): 482.     CrossRef
  • Association between Texture Analysis Parameters and Molecular Biologic KRAS Mutation in Non-Mucinous Rectal Cancer
    Sung Jae Jo, Seung Ho Kim, Sang Joon Park, Yedaun Lee, Jung Hee Son
    Journal of the Korean Society of Radiology.2021; 82(2): 406.     CrossRef
  • Actualización de la recomendación para la determinación de biomarcadores en el carcinoma colorrectal. Consenso Nacional de la Sociedad Española de Oncología Médica y de la Sociedad Española de Anatomía Patológica
    Samuel Navarro, Miriam Cuatrecasas, Javier Hernández-Losa, Stefania Landolfi, Eva Musulén, Santiago Ramón y Cajal, Rocío García-Carbonero, Jesús García-Foncillas, Pedro Pérez-Segura, Ramón Salazar, Ruth Vera, Pilar García-Alfonso
    Revista Española de Patología.2021; 54(1): 41.     CrossRef
  • Texture analysis using T1-weighted images for muscles in Charcot-Marie-Tooth disease patients and volunteers
    Ji Hyun Lee, Young Cheol Yoon, Hyun Su Kim, Jae-Hun Kim, Byung-Ok Choi
    European Radiology.2021; 31(5): 3508.     CrossRef
  • Radiomics signature of brain metastasis: prediction of EGFR mutation status
    Guangyu Wang, Bomin Wang, Zhou Wang, Wenchao Li, Jianjun Xiu, Zhi Liu, Mingyong Han
    European Radiology.2021; 31(7): 4538.     CrossRef
  • Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice
    Francesca Coppola, Valentina Giannini, Michela Gabelloni, Jovana Panic, Arianna Defeudis, Silvia Lo Monaco, Arrigo Cattabriga, Maria Adriana Cocozza, Luigi Vincenzo Pastore, Michela Polici, Damiano Caruso, Andrea Laghi, Daniele Regge, Emanuele Neri, Rita
    Diagnostics.2021; 11(5): 756.     CrossRef
  • MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients
    ZhiYuan Zhang, LiJun Shen, Yan Wang, Jiazhou Wang, Hui Zhang, Fan Xia, JueFeng Wan, Zhen Zhang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics
    Jing Gao, Xiahan Chen, Xudong Li, Fei Miao, Weihuan Fang, Biao Li, Xiaohua Qian, Xiaozhu Lin
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer
    Zhuokai Zhuang, Zongchao Liu, Juan Li, Xiaolin Wang, Peiyi Xie, Fei Xiong, Jiancong Hu, Xiaochun Meng, Meijin Huang, Yanhong Deng, Ping Lan, Huichuan Yu, Yanxin Luo
    Journal of Translational Medicine.2021;[Epub]     CrossRef
  • Systematic Review on the Association of Radiomics with Tumor Biological Endpoints
    Agustina La Greca Saint-Esteven, Diem Vuong, Fabienne Tschanz, Janita E. van Timmeren, Riccardo Dal Bello, Verena Waller, Martin Pruschy, Matthias Guckenberger, Stephanie Tanadini-Lang
    Cancers.2021; 13(12): 3015.     CrossRef
  • Emerging applications of radiomics in rectal cancer: State of the art and future perspectives
    Min Hou, Ji-Hong Sun
    World Journal of Gastroenterology.2021; 27(25): 3802.     CrossRef
  • Spatial-Frequency dual-branch attention model for determining KRAS mutation status in colorectal cancer with T2-weighted MRI
    Yulan Ma, Jiawen Wang, Kai Song, Yan Qiang, Xiong Jiao, Juanjuan Zhao
    Computer Methods and Programs in Biomedicine.2021; 209: 106311.     CrossRef
  • Textural differences based on apparent diffusion coefficient maps for discriminating pT3 subclasses of rectal adenocarcinoma
    Zhi-Hua Lu, Kai-Jian Xia, Heng Jiang, Jian-Long Jiang, Mei Wu
    World Journal of Clinical Cases.2021; 9(24): 6987.     CrossRef
  • 2. Radiomics of MRI
    Koji Sakai
    Japanese Journal of Radiological Technology.2021; 77(8): 866.     CrossRef
  • Radiomics and machine learning applications in rectal cancer: Current update and future perspectives
    Arnaldo Stanzione, Francesco Verde, Valeria Romeo, Francesca Boccadifuoco, Pier Paolo Mainenti, Simone Maurea
    World Journal of Gastroenterology.2021; 27(32): 5306.     CrossRef
  • Role of MRI‑based radiomics in locally advanced rectal cancer (Review)
    Siyu Zhang, Mingrong Yu, Dan Chen, Peidong Li, Bin Tang, Jie Li
    Oncology Reports.2021;[Epub]     CrossRef
  • Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer
    Yanfen Cui, Huanhuan Liu, Jialiang Ren, Xiaosong Du, Lei Xin, Dandan Li, Xiaotang Yang, Dengbin Wang
    European Radiology.2020; 30(4): 1948.     CrossRef
  • Multi-branch cross attention model for prediction of KRAS mutation in rectal cancer with t2-weighted MRI
    JiaWen Wang, YanFen Cui, GuoHua Shi, JuanJuan Zhao, XiaoTang Yang, Yan Qiang, QianQian Du, Yue Ma, Ntikurako Guy-Fernand Kazihise
    Applied Intelligence.2020; 50(8): 2352.     CrossRef
  • Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer
    Zixing Huang, Wei Zhang, Du He, Xing Cui, Song Tian, Hongkun Yin, Bin Song
    Medicine.2020; 99(10): e19428.     CrossRef
  • PET/MRI Radiomics in Rectal Cancer: a Pilot Study on the Correlation Between PET- and MRI-Derived Image Features with a Clinical Interpretation
    Barbara Juarez Amorim, Angel Torrado-Carvajal, Shadi A Esfahani, Sara S Marcos, Mark Vangel, Dan Stein, David Groshar, Onofrio A Catalano
    Molecular Imaging and Biology.2020; 22(5): 1438.     CrossRef
  • MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC)
    Filippo Crimì, Giulia Capelli, Gaya Spolverato, Quoc Riccardo Bao, Anna Florio, Sebastiano Milite Rossi, Diego Cecchin, Laura Albertoni, Cristina Campi, Salvatore Pucciarelli, Roberto Stramare
    La radiologia medica.2020; 125(12): 1216.     CrossRef
  • Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
    P. García-Alfonso, R. García-Carbonero, J. García-Foncillas, P. Pérez-Segura, R. Salazar, R. Vera, S. Ramón y Cajal, J. Hernández-Losa, S. Landolfi, E. Musulén, M. Cuatrecasas, S. Navarro
    Clinical and Translational Oncology.2020; 22(11): 1976.     CrossRef
  • MRI-Based Texture Features as Potential Prognostic Biomarkers in Anaplastic Astrocytoma Patients Undergoing Surgical Treatment
    Yang Zhang, Chaoyue Chen, Yangfan Cheng, Danni Cheng, Fumin Zhao, Jianguo Xu
    Contrast Media & Molecular Imaging.2020; 2020: 1.     CrossRef
  • Preoperative prediction of perineural invasion and KRAS mutation in colon cancer using machine learning
    Yu Li, Aydin Eresen, Junjie Shangguan, Jia Yang, Al B. Benson, Vahid Yaghmai, Zhuoli Zhang
    Journal of Cancer Research and Clinical Oncology.2020; 146(12): 3165.     CrossRef
  • Diffusion-Weighted MRI and Diffusion Kurtosis Imaging to Detect RAS Mutation in Colorectal Liver Metastasis
    Vincenza Granata, Roberta Fusco, Chiara Risi, Alessandro Ottaiano, Antonio Avallone, Alfonso De Stefano, Robert Grimm, Roberta Grassi, Luca Brunese, Francesco Izzo, Antonella Petrillo
    Cancers.2020; 12(9): 2420.     CrossRef
  • CT Radiomics in Colorectal Cancer: Detection of KRAS Mutation Using Texture Analysis and Machine Learning
    Víctor González-Castro, Eva Cernadas, Emilio Huelga, Manuel Fernández-Delgado, Jacobo Porto, José Ramón Antunez, Miguel Souto-Bayarri
    Applied Sciences.2020; 10(18): 6214.     CrossRef
  • Cancer Genotypes Prediction and Associations Analysis From Imaging Phenotypes: A Survey on Radiogenomics
    Yao Wang, Yan Wang, Chunjie Guo, Xuping Xie, Sen Liang, Ruochi Zhang, Wei Pang, Lan Huang
    Biomarkers in Medicine.2020; 14(12): 1151.     CrossRef
  • Diagnostic performance of multiparametric MRI parameters for Gleason score and cellularity metrics of prostate cancer in different zones: a quantitative comparison
    J. Gao, Q. Zhang, C. Zhang, M. Chen, D. Li, Y. Fu, X. Lv, B. Zhang, H. Guo
    Clinical Radiology.2019; 74(11): 895.e17.     CrossRef
  • Ability of Radiomics in Differentiation of Anaplastic Oligodendroglioma From Atypical Low-Grade Oligodendroglioma Using Machine-Learning Approach
    Yang Zhang, Chaoyue Chen, Yangfan Cheng, Yuen Teng, Wen Guo, Hui Xu, Xuejin Ou, Jian Wang, Hui Li, Xuelei Ma, Jianguo Xu
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • The Diagnostic Value of Radiomics-Based Machine Learning in Predicting the Grade of Meningiomas Using Conventional Magnetic Resonance Imaging: A Preliminary Study
    Chaoyue Chen, Xinyi Guo, Jian Wang, Wen Guo, Xuelei Ma, Jianguo Xu
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • 11,624 View
  • 403 Download
  • 55 Web of Science
  • 54 Crossref
Close layer
Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal Cancer
Jung Ryul Oh, Boram Park, Seongdae Lee, Kyung Su Han, Eui-Gon Youk, Doo-Han Lee, Do-Sun Kim, Doo-Seok Lee, Chang Won Hong, Byung Chang Kim, Bun Kim, Min Jung Kim, Sung Chan Park, Dae Kyung Sohn, Hee Jin Chang, Jae Hwan Oh
Cancer Res Treat. 2019;51(4):1275-1284.   Published online January 17, 2019
DOI: https://doi.org/10.4143/crt.2018.569
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Predicting lymph node metastasis (LNM) risk is crucial in determining further treatment strategies following endoscopic resection of T1 colorectal cancer (CRC). This study aimed to establish a new prediction model for the risk of LNM in T1 CRC patients.
Materials and Methods
The development set included 833 patients with T1 CRC who had undergone endoscopic (n=154) or surgical (n=679) resection at the National Cancer Center. The validation set included 722 T1 CRC patients who had undergone endoscopic (n=249) or surgical (n=473) resection at Daehang Hospital. A logistic regression model was used to construct the prediction model. To assess the performance of prediction model, discrimination was evaluated using the receiver operating characteristic (ROC) curves with area under the ROC curve (AUC), and calibration was assessed using the Hosmer-Lemeshow (HL) goodness-of-fit test.
Results
Five independent risk factors were determined in the multivariable model, including vascular invasion, high-grade histology, submucosal invasion, budding, and background adenoma. In final prediction model, the performance of the model was good that the AUC was 0.812 (95% confidence interval [CI], 0.770 to 0.855) and the HL chi-squared test statistic was 1.266 (p=0.737). In external validation, the performance was still good that the AUC was 0.771 (95% CI, 0.708 to 0.834) and the p-value of the HL chi-squared test was 0.040. We constructed the nomogram with the final prediction model.
Conclusion
We presented an externally validated new prediction model for LNM risk in T1 CRC patients, guiding decision making in determining whether additional surgery is required after endoscopic resection of T1 CRC.

Citations

Citations to this article as recorded by  
  • Risk stratification scores for lymph node metastases in T1 colorectal cancer—A systematic review
    Rakesh Quinn, Giuleta Jamsari, Ewan MacDermid
    Colorectal Disease.2025;[Epub]     CrossRef
  • The critical role of tumor size in predicting lymph node metastasis in early-stage colorectal cancer
    Attila Ulkucu, Metincan Erkaya, Ekin Inal, Emre Gorgun
    The American Journal of Surgery.2025; 241: 116152.     CrossRef
  • Risk assessment in pT1 colorectal cancer
    Emma Jane Norton, Adrian C Bateman
    Journal of Clinical Pathology.2024; 77(4): 225.     CrossRef
  • Curative criteria for endoscopic treatment of colorectal cancer
    Lucille Quénéhervé, Mathieu Pioche, Jérémie Jacques
    Best Practice & Research Clinical Gastroenterology.2024; 68: 101883.     CrossRef
  • Commentary: An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer
    Katsuro Ichimasa, Shin-ei Kudo, Khay Guan Yeoh
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Management after non-curative endoscopic resection of T1 rectal cancer
    Hao Dang, Daan A. Verhoeven, Jurjen J. Boonstra, Monique E. van Leerdam
    Best Practice & Research Clinical Gastroenterology.2024; 68: 101895.     CrossRef
  • A clinical-radiomics nomogram based on spectral CT multi-parameter images for preoperative prediction of lymph node metastasis in colorectal cancer
    Qian Li, Rui Hong, Ping Zhang, Liting Hou, Hailun Bao, Lin Bai, Jian Zhao
    Clinical & Experimental Metastasis.2024; 41(5): 639.     CrossRef
  • A new clinical model for predicting lymph node metastasis in T1 colorectal cancer
    Kai Wang, Hui He, Yanyun Lin, Yanhong Zhang, Junguo Chen, Jiancong Hu, Xiaosheng He
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions
    Xu Song, Jun Li, Jiang Zhu, Yun-Fei Kong, Yu-Hang Zhou, Zi-Kun Wang, Jin Zhang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Approaches and considerations in the endoscopic treatment of T1 colorectal cancer
    Yunho Jung
    The Korean Journal of Internal Medicine.2024; 39(4): 563.     CrossRef
  • A Nomogram for Predicting Unplanned Intraoperative Hypothermia in Patients With Colorectal Cancer Undergoing Laparoscopic Colorectal Procedures
    Lupei Yan, Jingxing Tan, Hao Chen, Han Xiao, Yi Zhang, Qin Yao, Yuerong Li
    AORN Journal.2023;[Epub]     CrossRef
  • A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer
    Zhenghua Piao, Rong Ge, Chunnian Wang
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study
    Yoshiki Kajiwara, Shiro Oka, Shinji Tanaka, Takahiro Nakamura, Shoichi Saito, Yosuke Fukunaga, Manabu Takamatsu, Hiroshi Kawachi, Kinichi Hotta, Hiroaki Ikematsu, Motohiro Kojima, Yutaka Saito, Masayoshi Yamada, Yukihide Kanemitsu, Shigeki Sekine, Shinji
    Gastrointestinal Endoscopy.2023; 97(6): 1119.     CrossRef
  • CT morphological features for predicting the risk of lymph node metastasis in T1 colorectal cancer
    Suyun Li, Zhenhui Li, Li Wang, Mimi Wu, Xiaobo Chen, Chutong He, Yao Xu, Mengyi Dong, Yanting Liang, Xin Chen, Zaiyi Liu
    European Radiology.2023; 33(10): 6861.     CrossRef
  • Prediction model for lymph node metastasis in superficial colorectal cancer: a better choice than computed tomography
    Chao-Tao Tang, Jun Li, Peng Wang, You-Xiang Chen, Chun-Yan Zeng
    Surgical Endoscopy.2023; 37(10): 7444.     CrossRef
  • Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence: A Multicentre Study
    Karmele Saez de Gordoa, Maria Teresa Rodrigo-Calvo, Ivan Archilla, Sandra Lopez-Prades, Alba Diaz, Jordi Tarragona, Isidro Machado, Juan Ruiz Martín, Diana Zaffalon, Maria Daca-Alvarez, Maria Pellisé, Jordi Camps, Miriam Cuatrecasas
    Cancers.2023; 15(22): 5481.     CrossRef
  • Prediction of disease recurrence or residual disease after primary endoscopic resection of pT1 colorectal cancer—results from a large nationwide Danish study
    Ilze Ose, Katarina Levic, Lau Caspar Thygesen, Orhan Bulut, Thue Bisgaard, Ismail Gögenur, Tine Plato Kuhlmann
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Endoscopic resection alone as a potential treatment method for low-risk deep invasive T1 colorectal cancer
    Yuta Kouyama, Shin-ei Kudo, Katsuro Ichimasa, Shingo Matsudaira, Yushi Ogawa, Kenichi Mochizuki, Yuki Takashina, Yuta Sato, Tatsuya Sakurai, Yasuharu Maeda, Hiroki Nakamura, Masashi Misawa, Yuichi Mori, Toyoki Kudo, Takemasa Hayashi, Kunihiko Wakamura, Te
    iGIE.2023; 2(4): 503.     CrossRef
  • A Retrospective Multicenter Study of Risk Factors, Stratification, and Prognosis of Lymph Node Metastasis in T1 and T2 Colorectal Cancer
    Eui Myung Kim, Il Tae Son, Byung Chun Kim, Jun Ho Park, Byung Mo Kang, Jong Wan Kim
    Journal of Clinical Medicine.2023; 12(24): 7744.     CrossRef
  • Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis
    Hao Dang, Nik Dekkers, Saskia le Cessie, Jeanin E. van Hooft, Monique E. van Leerdam, Philip P. Oldenburg, Louis Flothuis, Jan W. Schoones, Alexandra M.J. Langers, James C.H. Hardwick, Jolein van der Kraan, Jurjen J. Boonstra
    Clinical Gastroenterology and Hepatology.2022; 20(2): e298.     CrossRef
  • Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
    Xinxin Cheng, Yaxin Lu, Sai Chen, Weilin Yang, Bo Xu, Jianyong Zou, Zhenguang Chen
    Annals of Surgical Oncology.2022; 29(1): 598.     CrossRef
  • Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review
    Katsuro Ichimasa, Shin‐ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Yasuharu Maeda, Yuichi Mori, Toyoki Kudo, Yuki Miyata, Yoshika Akimoto, Yuki Kataoka, Takafumi Kubota, Tetsuo Nemoto, Fumio Ishida, Masashi Misawa
    Digestive Endoscopy.2022; 34(5): 901.     CrossRef
  • Tumor Location as a Prognostic Factor in T1 Colorectal Cancer
    Katsuro Ichimasa, Shin-ei Kudo, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Masashi Misawa, Yuichi Mori, Takemasa Hayashi, Kunihiko Wakamura, Hideyuki Miyachi
    Journal of the Anus, Rectum and Colon.2022; 6(1): 9.     CrossRef
  • Identification of Predictive Factors for Lymph Node Metastasis in pT1 Stage Colorectal Cancer Patients: A Retrospective Analysis Based on the Population Database
    Jiawei Song, Huanhuan Yin, Yong Zhu, Shengqi Fei
    Pathology and Oncology Research.2022;[Epub]     CrossRef
  • Establishment of a Dynamic Nomogram for Predicting the Risk of Lymph Node Metastasis in T1 Stage Colorectal Cancer
    Zitao Liu, Chao Huang, Huakai Tian, Yu Liu, Yongshan Huang, Zhengming Zhu
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis
    Liselotte W. Zwager, Barbara A.J. Bastiaansen, Nahid S.M. Montazeri, Roel Hompes, Valeria Barresi, Katsuro Ichimasa, Hiroshi Kawachi, Isidro Machado, Tadahiko Masaki, Weiqi Sheng, Shinji Tanaka, Kazutomo Togashi, Chihiro Yasue, Paul Fockens, Leon M.G. Moo
    Gastroenterology.2022; 163(1): 174.     CrossRef
  • Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer
    Jeong-ki Kim, Ye-Young Rhee, Jeong Mo Bae, Jung Ho Kim, Seong-Joon Koh, Hyun Jung Lee, Jong Pil Im, Min Jung Kim, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park, Ji Won Park, Gyeong Hoon Kang
    BMC Cancer.2022;[Epub]     CrossRef
  • Lymph node metastasis in T1 colorectal cancer with the only high-risk histology of submucosal invasion depth ≥ 1000 μm
    Yusuke Yamaoka, Akio Shiomi, Hiroyasu Kagawa, Hitoshi Hino, Shoichi Manabe, Kai Chen, Kenji Nanishi, Akifumi Notsu
    International Journal of Colorectal Disease.2022; 37(11): 2387.     CrossRef
  • Subpopulation analysis of survival in high-risk T1 colorectal cancer: surgery versus endoscopic resection only
    Ryun Kyong Ha, Boram Park, Kyung Su Han, Dae Kyung Sohn, Chang Won Hong, Byung Chang Kim, Bun Kim, Sung Chan Park, Hee Jin Chang, Jae Hwan Oh
    Gastrointestinal Endoscopy.2022; 96(6): 1036.     CrossRef
  • Preoperative prediction of lymph node status in patients with colorectal cancer. Developing a predictive model using machine learning
    Morten Hartwig, Karoline Bendix Bräuner, Rasmus Vogelsang, Ismail Gögenur
    International Journal of Colorectal Disease.2022; 37(12): 2517.     CrossRef
  • Preoperative Predictors of Lymph Node Metastasis in Colon Cancer
    Yansong Xu, Yi Chen, Chenyan Long, Huage Zhong, Fangfang Liang, Ling-xu Huang, Chuanyi Wei, Shaolong Lu, Weizhong Tang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer
    Jeonghyun Kang, Yoon Jung Choi, Im-kyung Kim, Hye Sun Lee, Hogeun Kim, Seung Hyuk Baik, Nam Kyu Kim, Kang Young Lee
    Cancer Research and Treatment.2021; 53(3): 773.     CrossRef
  • Risk Stratification of T1 Colorectal Cancer Metastasis to Lymph Nodes: Current Status and Perspective
    Katsuro Ichimasa, Shin-ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Masashi Misawa, Yuichi Mori
    Gut and Liver.2021; 15(6): 818.     CrossRef
  • Supervised Learning Based Systemic Inflammatory Markers Enable Accurate Additional Surgery for pT1NxM0 Colorectal Cancer: A Comparative Analysis of Two Practical Prediction Models for Lymph Node Metastasis
    Jinlian Jin, Haiyan Zhou, Shulin Sun, Zhe Tian, Haibing Ren, Jinwu Feng
    Cancer Management and Research.2021; Volume 13: 8967.     CrossRef
  • Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
    Kaibo Guo, Yuqian Feng, Li Yuan, Harpreet S. Wasan, Leitao Sun, Minhe Shen, Shanming Ruan
    Cancer Medicine.2020; 9(14): 5095.     CrossRef
  • Development and external validation of a predictive scoring system associated with metastasis of T1‐2 colorectal tumors to lymph nodes
    Shaobo Mo, Zheng Zhou, Weixing Dai, Wenqiang Xiang, Lingyu Han, Long Zhang, Renjie Wang, Sanjun Cai, Qingguo Li, Guoxiang Cai
    Clinical and Translational Medicine.2020; 10(1): 275.     CrossRef
  • Inverse Association of Age with Risk of Lymph Node Metastasis in Superficial Colorectal Cancer: A Large Population-Based Study
    Qing-Wei Zhang, Long-Ci Sun, Chao-Tao Tang, Qian Liang, Yang-Yang Zhou, Hui-Min Chen, Yun-Jie Gao, Zhi-Zheng Ge
    The Oncologist.2020; 25(6): e920.     CrossRef
  • T1 colorectal cancers: The impact of screening programs on a curable disease
    Adriana Vaz Safatle-Ribeiro
    Digestive and Liver Disease.2020; 52(8): 918.     CrossRef
  • Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies
    Wei Xu, Yazhou He, Yuming Wang, Xue Li, Jane Young, John P. A. Ioannidis, Malcolm G. Dunlop, Evropi Theodoratou
    BMC Medicine.2020;[Epub]     CrossRef
  • 10,203 View
  • 381 Download
  • 41 Web of Science
  • 39 Crossref
Close layer
Genetic Risk Score, Combined Lifestyle Factors and Risk of Colorectal Cancer
Young Ae Cho, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Cancer Res Treat. 2019;51(3):1033-1040.   Published online October 18, 2018
DOI: https://doi.org/10.4143/crt.2018.447
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Both genetic and lifestyle factors contribute to the risk of colorectal cancer, but each individual factor has a limited effect. Therefore, we investigated the association between colorectal cancer and the combined effects of genetic factors or/and lifestyle risk factors.
Materials and Methods
In a case-control study of 632 colorectal cancer patients and 1,295 healthy controls, we quantified the genetic risk score for colorectal cancer using 13 polymorphisms. Furthermore, we determined a combined lifestyle risk score including obesity, physical activity, smoking, alcohol consumption, and dietary inflammatory index. The associations between colorectal cancer and risk score using these factors were examined using a logistic regression model.
Results
Higher genetic risk scores were associated with an increased risk of colorectal cancer (odds ratio [OR], 2.57; 95% confidence interval [CI], 1.89 to 3.49 for the highest tertile vs. lowest tertile). Among the modifiable factors, previous body mass index, physical inactivity, heavy alcohol consumption, and a high inflammatory diet were associated with an increased risk of colorectal cancer. A higher lifestyle risk score was associated with an increased risk of colorectal cancer (OR, 5.82; 95% CI, 4.02 to 8.44 for the highest tertile vs. lowest tertile). This association was similar in each genetic risk category.
Conclusion
Adherence to a healthy lifestyle is associated with a substantially reduced risk of colorectal cancer regardless of individuals’ genetic risk.

Citations

Citations to this article as recorded by  
  • Sleep Duration, Dietary Inflammatory Potential, and Obesity in Relation to Colorectal Cancer Incidence in the Multiethnic Cohort
    Penias Tembo, Longgang Zhao, Loïc Le Marchand, Lynne R. Wilkens, Song-Yi Park, Christopher A. Haiman, Michael D. Wirth, James R. Hébert
    Nutrients.2025; 17(3): 370.     CrossRef
  • Design and Analysis of Surface Plasmon Resonance-Based Refractive Index Biosensor for Detection of Colorectal Cancer with Machine Learning Approach
    Yahya Ali Abdelrahman Ali, Trupti Kamani, Shobhit K. Patel, Taoufik Saidani, Abdulkarem H. M. Almawgani, Basim Ahmad Alabsi
    Plasmonics.2025;[Epub]     CrossRef
  • CD38 gene polymorphism rs1130169 contribution to the increased gene expression and risk of colorectal cancer (pilot study)
    Dmitry V. Novikov, Alexei D. Perenkov, Svetlana V. Shumilova, Nailya I. Kubysheva, Viktor V. Novikov
    Molecular Biology Reports.2024;[Epub]     CrossRef
  • Molecular subtype identification and prognosis stratification by a immunogenic cell death-related gene expression signature in colorectal cancer
    Junping Lei, Jia Fu, Tianyang Wang, Yu Guo, Mingmin Gong, Tian Xia, Song Shang, Yan Xu, Ling Cheng, Binghu Lin
    Expert Review of Anticancer Therapy.2024; 24(7): 635.     CrossRef
  • Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
    Yu Tian, Yi Lin, Conghui Qu, Volker Arndt, James W. Baurley, Sonja I. Berndt, Stephanie A. Bien, D. Timothy Bishop, Hermann Brenner, Daniel D. Buchanan, Arif Budiarto, Peter T. Campbell, Robert Carreras-Torres, Graham Casey, Andrew T. Chan, Rui Chen, Xuec
    British Journal of Cancer.2024; 130(10): 1687.     CrossRef
  • A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese population
    Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang
    Cancer Medicine.2024;[Epub]     CrossRef
  • Functionalized liposomes as a potential drug delivery systems for colon cancer treatment: A systematic review
    Eskandar Moghimipour, Somayeh Handali
    International Journal of Biological Macromolecules.2024; 269: 132023.     CrossRef
  • UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer
    Xuancheng Wang, Xuan Guan, Ying Tong, Yunxiao Liang, Zongsheng Huang, Mingsen Wen, Jichu Luo, Hongwei Chen, Shanyi Yang, Zhiyong She, Zhijuan Wei, Yun Zhou, Yali Qi, Pingchuan Zhu, Yanying Nong, Qisong Zhang
    BMC Cancer.2024;[Epub]     CrossRef
  • High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway
    Feng Li, Xing Wan, Zhigui Li, Liming Zhou
    Cancer Medicine.2024;[Epub]     CrossRef
  • Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
    Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Microbiota in gastrointestinal malignancies
    Ludovica Bricca, Serena Porcari, Edoardo Savarino, Massimo Rugge
    Best Practice & Research Clinical Gastroenterology.2024; 72: 101953.     CrossRef
  • Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers
    Raghuvaran Shanmugam, Prativa Majee, Wei Shi, Mert B. Ozturk, Thamil S. Vaiyapuri, Khaireen Idzham, Anandhkumar Raju, Seung H. Shin, Kerem Fidan, Joo-Leng Low, Joelle Y.H. Chua, Yap C. Kong, Ong Y. Qi, Emile Tan, Aik Y. Chok, Isaac Seow-En, Ian Wee, Domin
    Cancer Discovery.2024; 14(10): 1940.     CrossRef
  • An atlas on risk factors for gastrointestinal cancers: A systematic review of Mendelian randomization studies
    Yi-Xuan Huang, Jun-Hua Wu, Yu-Qiang Zhao, Wan-Nian Sui, Tian Tian, Wen-Xiu Han, Jing Ni
    Preventive Medicine.2024; 189: 108147.     CrossRef
  • Potential regulatory mechanism and clinical significance of synaptotagmin binding cytoplasmic RNA interacting protein in colorectal cancer
    Hui Li, He-Qing Huang, Zhi-Guang Huang, Rong-Quan He, Ye-Ying Fang, Rui Song, Jia-Yuan Luo, Da-Tong Zeng, Kai Qin, Dan-Ming Wei, Gang Chen
    World Journal of Clinical Oncology.2024; 15(11): 1412.     CrossRef
  • KRAS Gene Mutation Associated with Grade of Tumor Budding and Peripheral Immunoinflammatory Indices in Patients with Colorectal Cancer
    Liu Liang, Xuemin Guo, Wei Ye, Yuxiang Liu
    International Journal of General Medicine.2024; Volume 17: 4769.     CrossRef
  • Specifics of cancer detection at the outpatient stage. A case report
    O.S. Skuratova, S.N. Lagutina, P.Yu. Poyminova, A.E. Guzenko, G.A. Tyukov, A.A. Pashkova, N.S. Korchagina, E.Yu. Esina, I.S. Dobrynina
    Russian Journal of Preventive Medicine.2024; 27(10): 97.     CrossRef
  • Association of Methylenetetrahydrofolate Reductase Gene rs1801133 Polymorphism and Controlling Nutritional Status (CONUT) Score with Colorectal Cancer Susceptibility
    Zhuoxin Zhang, Zuguang Wu, Yuwen Zeng, Yunlin Li, Yingchuan Feng, Zhen Gao, Yijin Chen
    International Journal of General Medicine.2024; Volume 17: 6281.     CrossRef
  • Physical activity, polygenic risk score, and colorectal cancer risk
    Xuechen Chen, Feng Guo, Jenny Chang‐Claude, Michael Hoffmeister, Hermann Brenner
    Cancer Medicine.2023; 12(4): 4655.     CrossRef
  • Lifestyle, genetic risk and incidence of cancer: a prospective cohort study of 13 cancer types
    Stephanie Byrne, Terry Boyle, Muktar Ahmed, Sang Hong Lee, Beben Benyamin, Elina Hyppönen
    International Journal of Epidemiology.2023; 52(3): 817.     CrossRef
  • Association of blood pressure with incident diabetic microvascular complications among diabetic patients: Longitudinal findings from the UK Biobank
    Cong Li, Honghua Yu, Zhuoting Zhu, Xianwen Shang, Yu Huang, Charumathi Sabanayagam, Xiaohong Yang, Lei Liu
    Journal of Global Health.2023;[Epub]     CrossRef
  • Analysis of factors associated with postoperative acute kidney injury in patients with colorectal cancer and the development of a risk prediction model: a retrospective study
    Liu Li, Xiaochen Wan, Yonglei Zhang, Minghai Zhao, Jinjun Ren, Yongchao Zhang
    Updates in Surgery.2023; 75(5): 1171.     CrossRef
  • Exosomal Circ_FMN2 Derived from the Serum of Colorectal Cancer Patients Promotes Cancer Progression by miR-338-3p/MSI1 Axis
    Qiyao Yu, Yi Zhang, Yanming Tian, Ale Peng, Xiujing Cui, Boyue Ding, Lei Yang, Yabin Liu, Yingchao Ju, Chao Gao
    Applied Biochemistry and Biotechnology.2023; 195(12): 7322.     CrossRef
  • Green space exposure and colorectal cancer: A systematic review
    Noor Azreen Masdor, Maryam Fatimah Abu Bakar, Rozita Hod, Azmawati Mohammed Nawi
    Heliyon.2023; 9(5): e15572.     CrossRef
  • The Anti-Adhesion Effect of Nisin as a Robust Lantibiotic on the Colorectal Cancer Cells
    Hesam Soleimanifar, Hamideh Mahmoodzadeh Hosseini, Sadra Samavarchi Tehrani, Seyed Ali Mirhosseini
    Advanced Biomedical Research.2023;[Epub]     CrossRef
  • Colorectal cancer: epidemiology, carcinogenesis, molecular subtypes and cellular mechanisms of therapy resistance (analytical review)
    P. E. Maksimova, E. P. Golubinskaya, B. D. Seferov, E. Yu. Zyablitskaya
    Koloproktologia.2023; 22(2): 160.     CrossRef
  • The crosstalk between ubiquitin-conjugating enzyme E2Q1 and p53 in colorectal cancer: An in vitro analysis
    Maryam Rasouli, Sara Khakshournia, Omid Vakili, Sanaz Dastghaib, Atefeh Seghatoleslam, Sayed Mohammad Shafiee
    Medical Oncology.2023;[Epub]     CrossRef
  • Does postcholecystectomy increase the risk of colorectal cancer?
    Zhenyu Dong, Ruixian Shi, Pengda Li, Xiaobiao Song, Fan Dong, Jianmin Zhu, Riga Wu, Zhi Liang, Mingyue Du, Jijun Wang, Zhigang Yang
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer
    Joanna Słoka, Marcel Madej, Barbara Strzalka-Mrozik
    Molecules.2023; 28(13): 5081.     CrossRef
  • Colorectal Cancer: From Risk Factors to Oncogenesis
    Vlad Alexandru Ionescu, Gina Gheorghe, Nicolae Bacalbasa, Alexandru Laurentiu Chiotoroiu, Camelia Diaconu
    Medicina.2023; 59(9): 1646.     CrossRef
  • Modifiable Risk Factors in High-Risk Groups of Colorectal Cancer Screening: A Cross-Sectional Study with Propensity Score Method
    Xuan Zhong, Nongping Feng, Binfa Ouyang, Dan Zhao, Lin Lei, Ji Peng, Xiaolin Peng
    Risk Management and Healthcare Policy.2023; Volume 16: 2673.     CrossRef
  • Bioactive Peptides: Potential Impact on the Treatment of Gastrointestinal Cancers
    Ghazaleh Pourali, Danial Kazemi, Roozbeh Pourali, Nafise Rahmani, Erfan Razzaghi, Mina Maftooh, Hamid Fiuji, Elnaz Ghorbani, Majid Khazaei, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan
    Current Pharmaceutical Design.2023; 29(31): 2450.     CrossRef
  • A novel nutritional risk score and prognosis of oral cancer patients: A prospective study
    Qing Chen, Yi Fan, Yanni Li, Jing Wang, Lin Chen, Jing Lin, Fa Chen, Jing Wang, Yu Qiu, Bin Shi, Lizhen Pan, Lisong Lin, Baochang He, Fengqiong Liu
    Oral Diseases.2022; 28(1): 108.     CrossRef
  • Antecedentes familiares de primer grado como factor de riesgo en el cáncer colorrectal
    María Rubín-García, Vicente Martín, Facundo Vitelli-Storelli, Víctor Moreno, Nuria Aragonés, Eva Ardanaz, Jéssica Alonso-Molero, José J. Jiménez-Moleón, Pilar Amiano, Guillermo Fernández-Tardón, Ana Molina-Barceló, Juan Alguacil, María Dolores-Chirlaque,
    Gaceta Sanitaria.2022; 36(4): 345.     CrossRef
  • Diet and Genetic Risk Factors of Colorectal Cancer in Palestine: A Case-Control Study
    Issa Ghrouz, Nuha El Sharif
    Nutrition and Cancer.2022; 74(7): 2460.     CrossRef
  • Polygenic risk prediction models for colorectal cancer: a systematic review
    Michele Sassano, Marco Mariani, Gianluigi Quaranta, Roberta Pastorino, Stefania Boccia
    BMC Cancer.2022;[Epub]     CrossRef
  • Meta-Analysis of the Association between Dietary Inflammatory Index (DII) and Colorectal Cancer
    Sharifah Saffinas Syed Soffian, Azmawati Mohammed Nawi, Rozita Hod, Mohd Hasni Ja’afar, Zaleha Md Isa, Huan-Keat Chan, Muhammad Radzi Abu Hassan
    Nutrients.2022; 14(8): 1555.     CrossRef
  • Lack of Association Between PDCD-1 Polymorphisms and Colorectal Cancer Risk: A Case-Control Study
    Jing Lin, Hanshen Chen, Yufang Huang, Weifeng Tang, Sheng Zhang, Yu Chen
    Immunological Investigations.2022; 51(6): 1867.     CrossRef
  • Pro-Oxidant and Cytotoxic Effects of Tucum-Do-Cerrado (Bactris setosa Mart.) Extracts in Colorectal Adenocarcinoma Caco-2 Cells
    Renata Cristina da Silva, Raphael Rosa Fagundes, Klaas Nico Faber, Élida Geralda Campos
    Nutrition and Cancer.2022; 74(10): 3723.     CrossRef
  • Incidence, Mortality Features and Lifetime Risk Estimation of Digestive Tract Cancers in an Urban District of Shanghai, China
    Jing-Hao Bi, Hui-Yun Yuan, Yu Jiang, Yun Zhang, Wen-Wei Zheng, Lei Zhang, Zhuo-Ying Li, Hong-Lan Li, Yu-Ting Tan, Wen-Sui Zhao, Yong-Bing Xiang
    Journal of Epidemiology and Global Health.2022; 12(3): 248.     CrossRef
  • Combined Effect of Healthy Lifestyle Factors and Risks of Colorectal Adenoma, Colorectal Cancer, and Colorectal Cancer Mortality: Systematic Review and Meta-Analysis
    Jiazhou Yu, Qi Feng, Jean H. Kim, Yimin Zhu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • In silico high throughput screening and in vitro validation of a novel Raf/Mek dual inhibitor against colorectal carcinoma
    Hassan M. Otifi
    Biologia.2022; 77(12): 3555.     CrossRef
  • The importance of regulatory pathway mediated by Circ0001955 in colorectal cancer
    Sepideh Kadkhoda, Soudeh Ghafouri-Fard, Farshid Noorbakhsh, Sima Ravaei, Farzaneh Darbeheshti, Mahsa M. Amoli, Reza Taslimi, Abbas Shakoori
    Experimental and Molecular Pathology.2022; 128: 104819.     CrossRef
  • Early detection of colorectal cancer based on circular DNA and common clinical detection indicators
    Jian Li, Tao Jiang, Zeng-Ci Ren, Zhen-Lei Wang, Peng-Jun Zhang, Guo-An Xiang
    World Journal of Gastrointestinal Surgery.2022; 14(8): 833.     CrossRef
  • The Role of CEP55 Expression in Tumor Immune Response and Prognosis of Patients with Non-small Cell lung Cancer
    Haiyin Fan, Jin Zhang, Bin Zou, Zhisheng He
    Archives of Iranian Medicine.2022; 25(7): 432.     CrossRef
  • Exposome approach for identifying modifiable factors for the prevention of colorectal cancer
    Nanqian Chen, Hailun Liang, Tao Huang, Ninghao Huang
    Scientific Reports.2022;[Epub]     CrossRef
  • Metabolic pathways in sporadic colorectal carcinogenesis: A new proposal
    Sandra Caramujo-Balseiro, Carlos Faro, Lina Carvalho
    Medical Hypotheses.2021; 148: 110512.     CrossRef
  • Lifestyle Risk Score: handling missingness of individual lifestyle components in meta-analysis of gene-by-lifestyle interactions
    Hanfei Xu, Karen Schwander, Michael R. Brown, Wenyi Wang, R. J. Waken, Eric Boerwinkle, L. Adrienne Cupples, Lisa de las Fuentes, Diana van Heemst, Oyomoare Osazuwa-Peters, Paul S. de Vries, Ko Willems van Dijk, Yun Ju Sung, Xiaoyu Zhang, Alanna C. Morris
    European Journal of Human Genetics.2021; 29(5): 839.     CrossRef
  • Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy
    Xiaofei Miao, Ye Zhang, Zengyao Li, Longchang Huang, Taojian Xin, Renhui Shen, Tong Wang
    Molecular Therapy - Methods & Clinical Development.2021; 20: 442.     CrossRef
  • Polygenic risk score, healthy lifestyles, and risk of incident depression
    Zhi Cao, Hongxi Yang, Yixuan Ye, Yuan Zhang, Shu Li, Hongyu Zhao, Yaogang Wang
    Translational Psychiatry.2021;[Epub]     CrossRef
  • Analysis of multi-omics differences in left-side and right-side colon cancer
    Yanyi Huang, Jinzhong Duanmu, Yushu Liu, Mengyun Yan, Taiyuan Li, Qunguang Jiang
    PeerJ.2021; 9: e11433.     CrossRef
  • Individual and Joint Associations of Genetic Risk and Healthy Lifestyle Score with Colorectal Neoplasms Among Participants of Screening Colonoscopy
    Vanessa Erben, Prudence R. Carr, Feng Guo, Korbinian Weigl, Michael Hoffmeister, Hermann Brenner
    Cancer Prevention Research.2021; 14(6): 649.     CrossRef
  • Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer
    Marjan Ostovarpour, Mohammad Khalaj-Kondori, Tayyebeh Ghasemi
    Molecular Biology Reports.2021; 48(5): 4581.     CrossRef
  • Solanaceous Vegetables and Colorectal Cancer Risk: A Hospital-Based Matched Case-Control Study in Northeast China
    Yang Liu, Simin Li, Liqing Jiang, Yuchong Zhang, Zhi Li, Jing Shi
    Frontiers in Nutrition.2021;[Epub]     CrossRef
  • Lifestyle Score and Genetic Factors With Hypertension and Blood Pressure Among Adults in Rural China
    Miaomiao Niu, Liying Zhang, Yikang Wang, Runqi Tu, Xiaotian Liu, Chongjian Wang, Ronghai Bie
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • Importance of Circ0009910 in colorectal cancer pathogenesis as a possible regulator of miR-145 and PEAK1
    Sepideh Kadkhoda, Reza Taslimi, Farshid Noorbakhsh, Farzaneh Darbeheshti, Javad Tavakkoly Bazzaz, Soudeh Ghafouri-Fard, Abbas Shakoori
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • Cancer death and potential years of life lost in Feicheng City, China
    Jia Yang, Li Zhao, Nan Zhang, Zhenhua Du, Yanyan Li, Xia Li, Deli Zhao, Jialin Wang
    Medicine.2021; 100(39): e27370.     CrossRef
  • A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility
    Justina Ucheojor Onwuka, Dapeng Li, Yupeng Liu, Hao Huang, Jing Xu, Ying Liu, Yuanyuan Zhang, Yashuang Zhao
    BMC Cancer.2020;[Epub]     CrossRef
  • A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis
    Haitao Chen, Fan Zhang, Jin Zhang, Xinjie Zhang, Yong Guo, Qinghua Yao
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Gastric cancer risk: between genetics and lifestyle
    Massimo Rugge
    The Lancet Oncology.2020; 21(10): 1258.     CrossRef
  • Barriers of colorectal cancer screening test among adults in the Saudi Population: A Cross-Sectional study
    Shatha A. Alduraywish, Leen A. Altamimi, Ashwaq A. Almajed, Bushra A. Kokandi, Rawan S. Alqahtani, Shatha G. Alghaihb, Fahad M. Aldakheel
    Preventive Medicine Reports.2020; 20: 101235.     CrossRef
  • Protective Effect of Green Tea Consumption on Colorectal Cancer Varies by Lifestyle Factors
    Hyejin Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
    Nutrients.2019; 11(11): 2612.     CrossRef
  • The Effect of Aerobic Training with Purslane (Portulaca Oleracea) Seed on Toll Like Receptors in Colon Tumor Tissue of Adult Rats with Colon Cancer
    Abdol Kheder Keshtvarz, Maghsoud Peeri, Mohammad Ali Azarbayjani, Seyed Ali Hosseini
    Jorjani Biomedicine Journal.2019; 7(4): 49.     CrossRef
  • 19,495 View
  • 477 Download
  • 64 Web of Science
  • 62 Crossref
Close layer
Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer
Kyung Su Han, Dae Kyung Sohn, Dae Yong Kim, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Sun Young Kim, Ji Yeon Baek, Sung Chan Park, Min Ju Kim, Jae Hwan Oh
Cancer Res Treat. 2016;48(2):567-573.   Published online September 22, 2015
DOI: https://doi.org/10.4143/crt.2015.195
AbstractAbstract PDFPubReaderePub
Purpose
Local excision may be an another option for selected patients with markedly down-staged rectal cancer after preoperative chemoradiation therapy (CRT), and proper evaluation of post-CRT tumor stage (ypT) is essential prior to local excision of these tumors. This study was designed to determine the correlations between endoscopic findings and ypT of rectal cancer.
Materials and Methods
In this study, 481 patients with locally advanced rectal cancer who underwent preoperative CRT followed by surgical resection between 2004 and 2013 at a single institution were evaluated retrospectively. Pathological good response (p-GR) was defined as ypT ≤ 1, and pathological minimal or no response (p-MR) as ypT ≥ 2. The patients were randomly classified according to two groups, a testing (n=193) and a validation (n=288) group. Endoscopic criteria were determined from endoscopic findings and ypT in the testing group and used in classifying patients in the validation group as achieving or not achieving p-GR.
Results
Based on findings in the testing group, the endoscopic criteria for p-GR included scarring, telangiectasia, and erythema, whereas criteria for p-MR included nodules, ulcers, strictures, and remnant tumors. In the validation group, the kappa statistic was 0.965 (p < 0.001), and the sensitivity, specificity, positive predictive value, and negative predictive value were 0.362, 0.963, 0.654, and 0.885, respectively.
Conclusion
The endoscopic criteria presented are easily applicable for evaluation of ypT after preoperative CRT for rectal cancer. These criteria may be used for selection of patients for local excision of down-staged rectal tumors, because patients with p-MR could be easily ruled out.

Citations

Citations to this article as recorded by  
  • The value of multimodality MR in T staging evaluation after neoadjuvant therapy for rectal cancer
    Bin Liu, Chuan Sun, Xinyu Zhao, Lingyu Liu, Shuang Liu, Haichuan Ma
    Technology and Health Care.2024; 32(2): 615.     CrossRef
  • Feasibility of endoscopic techniques in assessing the radicality of chemoradiotherapy in patients with rectal cancer
    A. A. Salimova, M. V. Makarova, M. Yu. Kurdanova, Yu. P. Kuvshinov, I. A. Karasev, T. S. Davydkina
    Surgery and Oncology.2024; 14(2): 48.     CrossRef
  • Clinical predictors of pathological good response in locally advanced rectal cancer
    Kongfeng Shao, Rong Zheng, Anchuan Li, Xiaobo Li, Benhua Xu
    Radiation Oncology.2021;[Epub]     CrossRef
  • A prospective clinical study assessing the presence of exfoliated cancer cells and rectal washout including tumors in patients who receive neoadjuvant chemoradiotherapy for rectal cancer
    Kazutake Okada, Sotaro Sadahiro, Yutaro Kamei, Lin Fung Chan, Takashi Ogimi, Hiroshi Miyakita, Gota Saito, Akira Tanaka, Toshiyuki Suzuki
    Surgery Today.2020; 50(4): 352.     CrossRef
  • Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross‐Sectional Study with Rectal Preservation as Supported by Surgeon
    Kwang‐Seop Song, Sung Chan Park, Dae Kyung Sohn, Jae Hwan Oh, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Seung‐Yong Jeong, Kyu Joo Park, Heung‐Kwon Oh, Duck‐Woo Kim, Sung‐Bum Kang
    World Journal of Surgery.2019; 43(12): 3216.     CrossRef
  • Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer
    Dae Kyung Sohn, Kyung Su Han, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Ji Yeon Baek, Min Ju Kim, Sung Chan Park, Jae Hwan Oh, Dae Yong Kim
    Surgical Oncology.2017; 26(4): 453.     CrossRef
  • Advances in organ preserving strategies in rectal cancer patients
    Rutger CH. Stijns, Mike-Stephen R. Tromp, Niek Hugen, Johannes HW de Wilt
    European Journal of Surgical Oncology.2017;[Epub]     CrossRef
  • 12,295 View
  • 124 Download
  • 9 Web of Science
  • 7 Crossref
Close layer
Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-Term Outcomes
Yong Sok Kim, Min Jung Kim, Sung Chan Park, Dae Kyung Sohn, Dae Yong Kim, Hee Jin Chang, Byung-Ho Nam, Jae Hwan Oh
Cancer Res Treat. 2016;48(1):225-231.   Published online March 11, 2015
DOI: https://doi.org/10.4143/crt.2014.365
AbstractAbstract PDFPubReaderePub
Purpose
Robotic surgery is expected to have advantages over laparoscopic surgery; however, there are limited data regarding the feasibility of robotic surgery for rectal cancer after preoperative chemoradiotherapy (CRT). Therefore, we evaluated the short-term outcomes of robotic surgery for rectal cancer. Materials and Methods Thirty-three patients with cT3N0-2 rectal cancer after preoperative CRT who underwent robotic low anterior resection (R-LAR) between March 2010 and January 2012 were matched with 66 patients undergoing laparoscopic low anterior resection (L-LAR). Perioperative clinical outcomes and pathological data were compared between the two groups.
Results
Patient characteristics did not differ significantly different between groups. The mean operation time was 441 minutes (R-LAR) versus 277 minutes (L-LAR; p < 0.001). The open conversion rate was 6.1% in the R-LAR group and 0% in the L-LAR group (p=0.11). There were no significant differences in the time to flatus passage, length of hospital stay, and postoperative morbidity. In pathological review, the mean number of harvested lymph nodes was 22.3 in R-LAR and 21.6 in L-LAR (p=0.82). Involvement of circumferential resection margin was positive in 16.1% and 6.7%, respectively (p=0.42). Total mesorectal excision (TME) quality was complete in 97.0% in R-LAR and 91.0% in L-LAR (p=0.41). Conclusion In our study, short-term outcomes of robotic surgery for rectal cancer after CRT were similar to those of laparoscopic surgery in respect to bowel function recovery, morbidity, and TME quality. Well-designed clinical trials are needed to evaluate the functional results and longterm outcomes of robotic surgery for rectal cancer.

Citations

Citations to this article as recorded by  
  • Comparison of efficacy and safety between robotic-assisted versus laparoscopic surgery for locally advanced mid-low rectal cancer following neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
    Xin-Mao Zhu, Xiao Bai, Hai-Qi Wang, Dong-Qiu Dai
    International Journal of Surgery.2025; 111(1): 1154.     CrossRef
  • The role of robotic-assisted surgery in the management of rectal cancer: a systematic review and meta-analysis
    Chenxiong Zhang, Hao Tan, Han Xu, Jiaming Ding
    International Journal of Surgery.2024; 110(10): 6282.     CrossRef
  • Robotic-Assisted versus Laparoscopic Surgery for Rectal Cancer: An Analysis of Clinical and Financial Outcomes from a Tertiary Referral Center
    Jasper Max Gebhardt, Neno Werner, Andrea Stroux, Frank Förster, Ioannis Pozios, Claudia Seifarth, Christian Schineis, Benjamin Weixler, Katharina Beyer, Johannes Christian Lauscher
    Journal of Clinical Medicine.2024; 13(6): 1795.     CrossRef
  • Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer
    Muhammad Bilal Mirza, Adriana C. Gamboa, Rebecca Irlmeier, Benjamin Hopkins, Scott E. Regenbogen, Katherine A. Hrebinko, Jennifer Holder-Murray, Jason T. Wiseman, Aslam Ejaz, Paul E. Wise, Fei Ye, Kamran Idrees, Alexander T. Hawkins, Glen C. Balch, Aimal
    Journal of Surgical Research.2024; 300: 494.     CrossRef
  • Rapidez y Precisión en la Comunicación en Tiempo Real entre el Laboratorio Clínico y el Médico durante la Cirugía Robótica
    Alfredo Ibarra-Sánchez, Claudia Soto-Félix, Leticia Cano-Barraza, Delia Barraza-Sámano
    Estudios y Perspectivas Revista Científica y Académica .2024; 4(4): 1463.     CrossRef
  • Surgical outcomes of robotic, laparoscopic, and open low anterior resection after preoperative chemoradiotherapy for patients with advanced lower rectal cancer
    Sukchol Lim, Yuzo Nagai, Hiroaki Nozawa, Kazushige Kawai, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Tsuyoshi Ozawa, Shinya Abe, Hiroyuki Anzai, Hirofumi Sonoda, Soichiro Ishihara
    Surgery Today.2023; 53(1): 109.     CrossRef
  • Operative and oncological outcomes after robotic rectal resection compared with laparoscopy: a systematic review and meta‐analysis
    Julie Flynn, Jose T. Larach, Joseph C. H. Kong, Jessica Rahme, Peadar S. Waters, Satish K. Warrier, Alexander Heriot
    ANZ Journal of Surgery.2023; 93(3): 510.     CrossRef
  • Comparison of Operative Time Between Robotic and Laparoscopic Low Anterior Resection for Rectal Cancer:A Systematic Review and Meta-Analysis
    Zhen Chen, Hua Yu, Huaping Wu, Pingxi Wang, Fanwei Zeng
    Surgical Innovation.2023; 30(3): 390.     CrossRef
  • Robotic Rectal Resection for Rectal Cancer in Elderly Patients: A Systematic Review and Meta-Analysis
    Rossella Reddavid, Silvia Sofia, Lucia Puca, Jacopo Moro, Simona Ceraolo, Rosa Jimenez-Rodriguez, Maurizio Degiuli
    Journal of Clinical Medicine.2023; 12(16): 5331.     CrossRef
  • Short-term and long-term efficacy in robot-assisted treatment for mid and low rectal cancer: a systematic review and meta-analysis
    Huiming Wu, Renkai Guo, Huiyu Li
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Robotic versus laparoscopic surgery for rectal cancer after neoadjuvant chemoradiotherapy: A propensity-score matching analysis
    Tzu-Chun Chen, Jin-Tung Liang
    Journal of the Formosan Medical Association.2022; 121(8): 1532.     CrossRef
  • Short‐term outcomes of robotic‐assisted surgery following neoadjuvant chemotherapy for lower rectal cancer
    Hajime Morohashi, Yoshiyuki Sakamoto, Takuya Miura, Daichi Ichinohe, Shunsuke Kubota, Keisuke Yamazaki, Aika Ichisawa, Yuto Mitsuhashi, Taiichi Wakiya, Kenichi Hakamada
    Asian Journal of Endoscopic Surgery.2022; 15(3): 577.     CrossRef
  • Robotic versus Laparoscopic Low Anterior Resection for Rectal Cancer
    Aba Khaled M. Farid Uddin
    World Journal of Colorectal Surgery.2022; 11(3): 47.     CrossRef
  • Oncological outcomes of robotic-assisted total mesorectal excision after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
    Po-Jung Chen, Wei-Chih Su, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Tzu-Chieh Yin, Hsiang-Lin Tsai, Cheng-Jen Ma, Ching-Wen Huang, Jaw-Yuan Wang
    Asian Journal of Surgery.2021; 44(7): 957.     CrossRef
  • Difference in surgical outcomes of rectal cancer by study design: meta-analyses of randomized clinical trials, case-matched studies, and cohort studies
    N Hoshino, T Sakamoto, K Hida, Y Takahashi, H Okada, K Obama, T Nakayama
    BJS Open.2021;[Epub]     CrossRef
  • Postoperative complications observed with robotic versus laparoscopic surgery for the treatment of rectal cancer
    Chengkui Liu, Xiaoqing Li, Qingfeng Wang
    Medicine.2021; 100(36): e27158.     CrossRef
  • Robotic and robotic-assisted vs laparoscopic rectal cancer surgery: A meta-analysis of short-term and long-term results
    Guojun Tong, Guiyang Zhang, Zhaozheng Zheng
    Asian Journal of Surgery.2021;[Epub]     CrossRef
  • Robotic-Assisted vs. Standard Laparoscopic Surgery for Rectal Cancer Resection: A Systematic Review and Meta-Analysis of 19,731 Patients
    Kamil Safiejko, Radoslaw Tarkowski, Maciej Koselak, Marcin Juchimiuk, Aleksander Tarasik, Michal Pruc, Jacek Smereka, Lukasz Szarpak
    Cancers.2021; 14(1): 180.     CrossRef
  • Robotic versus Laparoscopic Colorectal Surgeries
    Anil Heroor, Aysha Khan, Kashish Jain, Akshay Patil, Hitesh Rajendra Singhavi
    Indian Journal of Colo-Rectal Surgery.2021; 4(1): 12.     CrossRef
  • Feasibility of robot-assisted surgery in elderly patients with rectal cancer
    Wei-Chih Su, Ching-Wen Huang, Cheng-Jen Ma, Po-Jung Chen, Hsiang-Lin Tsai, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Yung-Sung Yeh, Jaw-Yuan Wang
    Journal of Minimal Access Surgery.2021; 17(2): 165.     CrossRef
  • Robotic surgery for colorectal disease: review of current port placement and future perspectives
    Jong Lyul Lee, Hassan A. Alsaleem, Jin Cheon Kim
    Annals of Surgical Treatment and Research.2020; 98(1): 31.     CrossRef
  • Comparison of clinical efficacy between robotic-laparoscopic excision and traditional laparoscopy for rectal cancer
    Zhen Chen, Zhuo Li Zhu, Pingxi Wang, Fanwei Zeng
    Medicine.2020; 99(27): e20704.     CrossRef
  • Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer
    Tzu-Chieh Yin, Wei-Chih Su, Po-Jung Chen, Tsung-Kun Chang, Yen-Cheng Chen, Ching-Chun Li, Yi-Chien Hsieh, Hsiang-Lin Tsai, Ching-Wen Huang, Jaw-Yuan Wang
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Robotic Total Mesorectal Excision for Rectal Cancer: Current Evidences and Future Perspectives
    Je-Ho Jang, Chang-Nam Kim
    Annals of Coloproctology.2020; 36(5): 293.     CrossRef
  • Systematic review analysis of robotic and transanal approaches in TME surgery- A systematic review of the current literature in regard to challenges in rectal cancer surgery
    Julia K. Grass, Daniel R. Perez, Jakob R. Izbicki, Matthias Reeh
    European Journal of Surgical Oncology.2019; 45(4): 498.     CrossRef
  • Robotic Versus Conventional Laparoscopic Surgery for Colorectal Cancer: A Systematic Review and Meta‐Analysis with Trial Sequential Analysis
    Ka Ting Ng, Azlan Kok Vui Tsia, Vanessa Yu Ling Chong
    World Journal of Surgery.2019; 43(4): 1146.     CrossRef
  • Robotic versus conventional laparoscopic surgery for rectal cancer: systematic review and meta-analysis
    Xi-Yu Sun, Lai Xu, Jun-Yang Lu, Guan-Nan Zhang
    Minimally Invasive Therapy & Allied Technologies.2019; 28(3): 135.     CrossRef
  • Systemic review and network meta‐analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes
    Emanuele Rausa, Federica Bianco, Michael E. Kelly, Alberto Aiolfi, Fausto Petrelli, Gianluca Bonitta, Giovanni Sgroi
    Journal of Surgical Oncology.2019; 119(7): 987.     CrossRef
  • TME for rectal cancer: consecutive 70 patients treated with laparoscopic and robotic technique—cumulative experience in a single centre
    J. L. Mégevand, E. Lillo, M. Amboldi, L. Lenisa, A. Ambrosi, A. Rusconi
    Updates in Surgery.2019; 71(2): 331.     CrossRef
  • Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis
    Marco Milone, Michele Manigrasso, Nunzio Velotti, Stefania Torino, Antonietta Vozza, Giovanni Sarnelli, Giovanni Aprea, Francesco Maione, Nicola Gennarelli, Mario Musella, Giovanni Domenico De Palma
    International Journal of Colorectal Disease.2019; 34(6): 983.     CrossRef
  • Immediate results of robotic-assisted operations in colorectal surgery
    Yu. M. Stojko, A. V. Maksimenkov, A. L. Levchuk, D. A. Kolozyan
    Endoskopicheskaya khirurgiya.2019; 25(2): 5.     CrossRef
  • Short-Term Outcomes of Robotic versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Cohort Study
    Wen-Han Liu, Pei-Jing Yan, Dong-Ping Hu, Peng-Hui Jin, Yao-Chun Lv, Rong Liu, Xiong-Fei Yang, Ke-Hu Yang, Tian-Kang Guo
    The American Surgeon™.2019; 85(3): 294.     CrossRef
  • Operative time and length of stay is similar between robotic assisted and laparoscopic colon and rectal resections
    Heather R. Nolan, Betsy E. Smith, Michael D. Honaker
    Journal of Robotic Surgery.2018; 12(4): 659.     CrossRef
  • Does robotic rectal cancer surgery improve the results of experienced laparoscopic surgeons? An observational single institution study comparing 168 robotic assisted with 184 laparoscopic rectal resections
    Rogier M. P. H. Crolla, Paul G. Mulder, George P. van der Schelling
    Surgical Endoscopy.2018; 32(11): 4562.     CrossRef
  • Robotic total meso-rectal excision for rectal cancer: A systematic review following the publication of the ROLARR trial
    Katie Jones, Mohamed G Qassem, Parv Sains, Mirza K Baig, Muhammad S Sajid
    World Journal of Gastrointestinal Oncology.2018; 10(11): 449.     CrossRef
  • Recent surgical advances in colorectal cancer excision: toward optimal outcomes
    Cihangir Akyol, Mehmet Ayhan Kuzu
    Colorectal Cancer.2017; 5(4): 147.     CrossRef
  • The safety and effectiveness of robot-assisted versus laparoscopic TME in patients with rectal cancer
    Xiaofei Li, Tao Wang, Liang Yao, Lidong Hu, Penghui Jin, Tiankang Guo, Kehu Yang
    Medicine.2017; 96(29): e7585.     CrossRef
  • Robotic-assisted total mesorectal excision with the single-docking technique for patients with rectal cancer
    Ching-Wen Huang, Hsiang-Lin Tsai, Yung-Sung Yeh, Wei-Chih Su, Ming-Yii Huang, Chun-Ming Huang, Yu-Tang Chang, Jaw-Yuan Wang
    BMC Surgery.2017;[Epub]     CrossRef
  • Robotic Surgery for Rectal Cancer: An Update in 2015
    Jung Myun Kwak, Seon Hahn Kim
    Cancer Research and Treatment.2016; 48(2): 427.     CrossRef
  • La chirurgie robotique dans le cancer du rectum
    J. Coget, P. E. Colombo, A. Mourregot, D. Traoré, P. Rouanet
    Oncologie.2016; 18(5): 305.     CrossRef
  • Robot-assisted versus laparoscopic-assisted surgery for colorectal cancer: a meta-analysis
    Xuan Zhang, ZhengQiang Wei, MengJun Bie, XuDong Peng, Cheng Chen
    Surgical Endoscopy.2016; 30(12): 5601.     CrossRef
  • Robotics in Colorectal Surgery
    Allison Weaver, Scott Steele
    F1000Research.2016; 5: 2373.     CrossRef
  • 13,037 View
  • 134 Download
  • 41 Web of Science
  • 42 Crossref
Close layer
Single Immunochemical Fecal Occult Blood Test for Detection of Colorectal Neoplasia
Dae Kyung Sohn, Seung-Yong Jeong, Hyo Seong Choi, Seok-Byung Lim, Jin Myeong Huh, Dae-Hyun Kim, Dae Yong Kim, Young Hoon Kim, Hee Jin Chang, Kyung Hae Jung, Joong-Bae Ahn, Hyun Kyung Kim, Jae-Gahb Park
Cancer Res Treat. 2005;37(1):20-23.   Published online February 28, 2005
DOI: https://doi.org/10.4143/crt.2005.37.1.20
AbstractAbstract PDFPubReaderePub
Purpose

This study was designed to investigate the validity of a single immunochemical fecal occult blood test (FOBT) for detection of colorectal neoplasia.

Materials and Methods

A total of 3,794 average-risk screenees and 304 colorectal cancer patients admitted to the National Cancer Center, Korea, between May 2001 and November 2002, were studied prospectively. All screenees and admitted patients underwent FOBT and total colonoscopic examinations. Stools were self-collected, and examined using an immunochemical fecal occult blood test (OC-hemodia®, Eiken Chemical Co. Tokyo, Japan) and an OC-sensor analyzer® (Eiken Chemical Co. Tokyo, Japan).

Results

Of the 3,794 asymptomatic screenees, the colonoscopy identified colorectal adenomas and cancers in 613 (16.2%) and 12 (0.3%) subjects, respectively. The sensitivities of a single immunochemical FOBT for detecting colorectal cancers and adenomas in screenees were 25.0 and 2.4%, respectively. The false positive rate of FOBT for colorectal cancer in screenees was 1.19%. For the total 316 colorectal cancer cases (including 12 cases from screenees), the FOBT sensitivities according to the T-stage were 38.5, 75.0%, 78.9 and 79.2% for T1, 2, 3 and 4 cancers, respectively. The sensitivities according to the Dukes stages A, B and C were 63.4, 79.3 and 78.6%, respectively.

Conclusion

The sensitivities of a single immunochemical FOBT for detecting colorectal cancers and adenomas in screenees were 25.0 and 2.4%, respectively. The sensitivities of FOBT were about 80% for Dukes B or C colorectal cancers and 63.4% for Dukes A.

Citations

Citations to this article as recorded by  
  • Interval Advanced Adenomas and Neoplasia in Patients with Negative Colonoscopy Following Positive Stool-Based Colorectal Cancer Screening Test
    Kyle S. Liu, Rollin George, Caleb Shin, Jia Q. Xiong, Taher Jamali, Yan Liu, Priya Roy, Sonia Singh, Samuel Ma, Hashem B. El-Serag, Mimi C. Tan
    Digestive Diseases and Sciences.2025; 70(1): 350.     CrossRef
  • Findings in the distal and proximal colon in colonoscopy screening after positive FIT and related pre-procedure factors
    M.� Henar Núñez Rodríguez, Pilar Díez Redondo, Fausto Riu Pons, Marta Cimavilla, Andrea Loza, Manuel Perez-Miranda
    Revista Española de Enfermedades Digestivas.2022;[Epub]     CrossRef
  • Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals
    Esmée J Grobbee, Pieter HA Wisse, Eline H Schreuders, Aafke van Roon, Leonie van Dam, Ann G Zauber, Iris Lansdorp-Vogelaar, Wichor Bramer, Sarah Berhane, Jonathan J Deeks, Ewout W Steyerberg, Monique E van Leerdam, Manon CW Spaander, Ernst J Kuipers
    Cochrane Database of Systematic Reviews.2022;[Epub]     CrossRef
  • Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-analysis
    Mohammad Yaghoobi, Parsa Mehraban Far, Lawrence Mbuagbaw, Yuhong Yuan, David Armstrong, Lehana Thabane, Paul Moayyedi
    Middle East Journal of Digestive Diseases.2022; 14(4): 382.     CrossRef
  • Guidelines for accreditation of endoscopy units: quality measures from the Korean Society of Coloproctology
    Rumi Shin, Seongdae Lee, Kyung-Su Han, Dae Kyung Sohn, Sang Hui Moon, Dong Hyun Choi, Bong-Hyeon Kye, Hae-Jung Son, Sun Il Lee, Sumin Si, Won-Kyung Kang
    Annals of Surgical Treatment and Research.2021; 100(3): 154.     CrossRef
  • Screening for Colorectal Cancer
    Jennifer S. Lin, Leslie A. Perdue, Nora B. Henrikson, Sarah I. Bean, Paula R. Blasi
    JAMA.2021; 325(19): 1978.     CrossRef
  • Colorectal Cancer Screening Outcomes of 2412 Prostate Cancer Patients Considered for Carbon Ion Radiotherapy
    Nao Kobayashi, Takahiro Oike, Nobuteru Kubo, Yuhei Miyasaka, Tatsuji Mizukami, Hiro Sato, Akiko Adachi, Hiroyuki Katoh, Hidemasa Kawamura, Tatsuya Ohno
    Cancers.2021; 13(17): 4481.     CrossRef
  • Evaluation of the Cut-Off Value of Fecal Immunochemical Test for Colorectal Cancer Screening during Health Checkups
    Hye-Ran Park, Eun-Hee Nah, Jong-Seon Lee, Seon Cho
    Journal of Laboratory Medicine and Quality Assurance.2021; 43(4): 190.     CrossRef
  • Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis
    Tobias Niedermaier, Yesilda Balavarca, Hermann Brenner
    American Journal of Gastroenterology.2020; 115(1): 56.     CrossRef
  • Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location
    Tobias Niedermaier, Kaja Tikk, Anton Gies, Stefanie Bieck, Hermann Brenner
    Clinical Gastroenterology and Hepatology.2020; 18(13): 2920.     CrossRef
  • Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps
    Thomas F. Imperiale, Rachel N. Gruber, Timothy E. Stump, Thomas W. Emmett, Patrick O. Monahan
    Annals of Internal Medicine.2019; 170(5): 319.     CrossRef
  • Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis
    Kevin Selby, Emma H. Levine, Cecilia Doan, Anton Gies, Hermann Brenner, Charles Quesenberry, Jeffrey K. Lee, Douglas A. Corley
    Gastroenterology.2019; 157(6): 1494.     CrossRef
  • Quantitative fecal immunochemical tests for colorectal cancer screening
    Anton Gies, Megha Bhardwaj, Christian Stock, Petra Schrotz‐King, Hermann Brenner
    International Journal of Cancer.2018; 143(2): 234.     CrossRef
  • Prevalence of functional gastrointestinal disorders in adults with systemic lupus erythematosus
    M García-Carrasco, C Mendoza-Pinto, M A Autrán-Limón, E Herrera Robles, S Méndez Martínez, I Etchegaray Morales, Á Montiel Jarquín, J L Gálvez Romero, P Soto-Santillán, J Galindo-Herrera, A López-Colombo
    Lupus.2018; 27(5): 788.     CrossRef
  • Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
    Dae Ho Kim, Jae Myung Cha, Min Seob Kwak, Jin Young Yoon, Young-Hak Cho, Jung Won Jeon, Hyun Phil Shin, Kwang Ro Joo, Joung Il Lee
    Gut and Liver.2018; 12(2): 183.     CrossRef
  • Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
    Douglas J. Robertson, Jeffrey K. Lee, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas K. Rex
    Gastroenterology.2017; 152(5): 1217.     CrossRef
  • Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer
    Douglas J. Robertson, Jeffrey K. Lee, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas K. Rex
    Gastrointestinal Endoscopy.2017; 85(1): 2.     CrossRef
  • Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
    Douglas J Robertson, Jeffrey K Lee, Richard C Boland, Jason A Dominitz, Francis M Giardiello, David A Johnson, Tonya Kaltenbach, David Lieberman, Theodore R Levin, Douglas K Rex
    American Journal of Gastroenterology.2017; 112(1): 37.     CrossRef
  • Risk Factors for False Fecal Immunochemical Test Results in Colorectal Cancer Screening
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Journal of Clinical Gastroenterology.2017; 51(2): 151.     CrossRef
  • Which Fecal Immunochemical Test Should I Choose?
    Jeanette M. Daly, Yinghui Xu, Barcey T. Levy
    Journal of Primary Care & Community Health.2017; 8(4): 264.     CrossRef
  • Cancer-Type Oatp1B3 mRNA Has the Potential to Become a Detection and Prognostic Biomarker for Human Colorectal Cancer
    Yuchen Sun, Manami Harada, Osamu Shimozato, Hiroaki Souda, Nobuhiro Takiguchi, Yoshihiro Nabeya, Takehiko Kamijo, Hidetaka Akita, Naohiko Anzai, Kan Chiba, Tomomi Furihata
    Biomarkers in Medicine.2017; 11(8): 629.     CrossRef
  • Screening of colorectal cancer: present and future
    Marcello Maida, Fabio Salvatore Macaluso, Gianluca Ianiro, Francesca Mangiola, Emanuele Sinagra, Georgina Hold, Carlo Maida, Giovanni Cammarota, Antonio Gasbarrini, Giuseppe Scarpulla
    Expert Review of Anticancer Therapy.2017; 17(12): 1131.     CrossRef
  • Age-adapted Variation in Screening Interval of Fecal Immunochemical Test May Improve its Participation and Colonoscopy Acceptance
    Min Seob Kwak, Jae Myung Cha, Jin Young Yoon, Jung Won Jeon, Hyun Phil Shin, Kwang Ro Joo, Joung Il Lee
    Journal of Clinical Gastroenterology.2017; 51(9): 825.     CrossRef
  • Use of a Low Cut-Off Value for the Fecal Immunochemical Test Enables Better Detection of Proximal Neoplasia
    Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jung Won Jeun, Jun Uk Lim
    Digestive Diseases and Sciences.2013; 58(11): 3256.     CrossRef
  • Performance of the Fecal Immunochemical Test Is Not Decreased by High Ambient Temperature in the Rapid Return System
    Jae Myung Cha, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jae Jun Park, Jung Won Jeun, Jun Uk Lim, Sang-Hyun Hwang
    Digestive Diseases and Sciences.2012; 57(8): 2178.     CrossRef
  • A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program
    Mi Jin Park, Kui Son Choi, You Kyoung Lee, Jae Kwan Jun, Hoo-Yeon Lee
    Scandinavian Journal of Gastroenterology.2012; 47(4): 461.     CrossRef
  • Clinical Features of Colorectal Cancer Detected by the National Cancer Screening Program
    Dae-Do Park, Rumi Shin, Ji-Sun Kim, Heung-Kwon Oh, Seung-Yong Jeong, Kyu Joo Park, Jae-Gahb Park
    Journal of the Korean Society of Coloproctology.2010; 26(6): 420.     CrossRef
  • The Significance of Fecal Immunochemical Test to Screen for Colorectal Cancer in National Cancer Screening Program
    Jun Uk Lim, Na Young Bae, Won Koung Song, Jae Myung Cha, Joung Il Lee
    Intestinal Research.2010; 8(2): 126.     CrossRef
  • False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening
    Leo G.M. van Rossum, Anne F. van Rijn, Martijn G.H. van Oijen, Paul Fockens, Robert J.F. Laheij, Andre L.M. Verbeek, Jan B.M.J. Jansen, Evelien Dekker
    International Journal of Cancer.2009; 125(4): 746.     CrossRef
  • Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme
    L G M van Rossum, A F van Rijn, R J F Laheij, M G H van Oijen, P Fockens, J B M J Jansen, A L M Verbeek, E Dekker
    British Journal of Cancer.2009; 101(8): 1274.     CrossRef
  • Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population
    Leo G. van Rossum, Anne F. van Rijn, Robert J. Laheij, Martijn G. van Oijen, Paul Fockens, Han H. van Krieken, Andre L. Verbeek, Jan B. Jansen, Evelien Dekker
    Gastroenterology.2008; 135(1): 82.     CrossRef
  • 11,059 View
  • 89 Download
  • 31 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP